Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Lymphoma 68Lymphoma, Non-Hodgkin 53Lymphoma, Large B-Cell, Diffuse 47Hodgkin Disease 42Precursor Cell Lymphoblastic Leukemia-Lymphoma 41Leukemia, Myeloid, Acute 41Small Cell Lung Carcinoma 37Leukemia 37Burkitt Lymphoma 32Lymphoma, Mantle-Cell 29Lymphoma, Follicular 28Lung Neoplasms 20Carcinoma, Non-Small-Cell Lung 20Multiple Myeloma 19Congenital Abnormalities 18Lymphoma, Large-Cell, Immunoblastic 17Lymphoma, Large-Cell, Anaplastic 17Recurrence 15Lymphoma, B-Cell, Marginal Zone 15Lymphoma, B-Cell 15Leukemia, Lymphocytic, Chronic, B-Cell 15Neuroblastoma 13Neoplasms 13Myelodysplastic Syndromes 11Waldenstrom Macroglobulinemia 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10Lymphoma, T-Cell 10Immunoblastic Lymphadenopathy 10Sarcoma 9Myeloproliferative Disorders 9

Interventions

tislelizumab 1Taxes 1Pemetrexed 1Paclitaxel 1Oxaliplatin 1Fluorouracil 1Etoposide 1Cisplatin 1Carboplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Locally Advanced and Metastatic Solid Tumors × Etoposide × Clear all
NCT04047862 2025-08-22

Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors

BeiGene

Phase 1 Completed
446 enrolled 49 charts
Other solid neoplasm

Locally Advanced and Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡